Evidence map›Paper›PMID 40305235›Full record

ArticleBiomolecules2025

Proteomic Profiling of Inflammatory Protein Dysregulation in HLA-B27-Positive Ankylosing Spondylitis: Molecular Signatures and Potential Biomarkers.

Yuzhu Yan, Jihan Wang, Yangyang Wang, Junye Liu, Wenjuan Yang, Min Niu, Yan Yu, Heping Zhao

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuzhu YanClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.ORCID 0000-0003-1355-0266
Jihan WangShaanxi Provincial Key Laboratory of Infection and Immune Diseases, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
Yangyang WangSchool of Electronics and Information, Northwestern Polytechnical University, Xi'an 710129, China.
Junye LiuClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.ORCID 0000-0001-5893-7785
Wenjuan YangClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
Min NiuDepartment of Rheumatology Immunology and Endocrinology, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
Yan YuClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
Heping ZhaoClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.

Funding

Project of Xi'an Science and Technology 22YXYJ0041the Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases 2023-KFMS-1
6 · The paper itself

Abstract

This study explored the proteomic landscape of inflammatory protein dysregulation in ankylosing spondylitis (AS), a chronic inflammatory disorder primarily affecting the axial skeleton and strongly associated with the HLA-B27 allele, particularly the HLA-B2705 and HLA-B2704 subtypes prevalent in Chinese populations. Blood samples from HLA-B27-positive AS patients and normal controls (NC) were analyzed using the Olink Target 96 inflammation panel to profile 92 inflammatory proteins. HLA-B27 subtyping was performed via PCR-SSP. To identify key proteins and stratify AS subtypes, we employed machine learning classifiers, including LightGBM models coupled with SHAP value interpretation, alongside traditional statistical analyses. The proteomic analysis revealed significant dysregulation of pro-inflammatory cytokines, such as IL-6 and IL-17A, in AS patients compared to NC, with CXCL9 and NRTN identified as potential biomarkers associated with disease activity. The combination of LightGBM classifiers and traditional statistical methods demonstrated high accuracy in distinguishing AS from NC and effectively stratifying subtypes. These findings provide valuable insights into the inflammatory mechanisms underlying AS pathogenesis and highlight potential biomarkers and therapeutic targets for improving diagnosis and treatment strategies. Future studies with larger and more diverse cohorts, as well as longitudinal designs, are warranted to validate these biomarkers and elucidate their dynamic changes during disease progression.

Indexed as

HLA-B27 AntigenProteomicsSpondylitis, AnkylosingAdultBiomarkersFemaleHumansInflammationInterleukin-17Interleukin-6Machine LearningMaleMiddle AgedBiomarkersHLA-B27 AntigenInterleukin-17Interleukin-6ankylosing spondylitiscytokine dysregulationHLA-B27inflammatory biomarkersproteomics

Identifiers

PMID40305235
PMCPMC12024590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.